Key result
Polyclonal antisera raised against 26 different norovirus virus-like particles demonstrated novel broad-range cross-reactivities among different genotypes driven by conserved amino acid residues.
Population
26 different Norovirus virus-like particles (VLPs) representing six GI and 12 GII genotypes
Design
Preclinical
Authors
Loading...
Informs norovirus vaccine epitope selection; leaves open human protection from animal antisera cross-reactivity.
Broad-range cross-reactivities among norovirus genotypes are influenced by conserved amino acid residues and VP1 secondary structures.
Hansman et al. (2006) studied Norovirus. Cross-reactivity analysis of NoV VLPs was evaluated on Antigenic cross-reactivity. Polyclonal antisera raised against 26 different norovirus virus-like particles demonstrated novel broad-range cross-reactivities among different genotypes driven by conserved amino acid residues.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: